IVIG vs SCIG in CIDP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IVIG vs SCIG in CIDP — Stella

View on ClinicalTrials.gov

Recruiting

Back to CIDP trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Rutgers, The State University of New Jersey Clinical Research Center, New Brunswick, New Jersey

Key details

Phase

Early testing

Sponsor

Rutgers, The State University of New Jersey

Enrollment target

~20 participants

Started

September 2022

Primary completion

December 2026

Age range

18 Years – 65 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.